San Francisco, CA, United States of America

Edmund J Moran

This inventor holds 48 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Innovations. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC, Advanced Medicine, Inc.. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edmund J Moran. Retrieved from https://idiyas.com/inventor/edmund-j-moran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 48 

% Patents Active = 93.8

 

 

Average Co-Inventor Count = 3.3

ph-index = 17

Forward Citations = 795(Granted Patents)


Location History:

  • Cardiff, CA (US) (1998)
  • San Francisco, CA (US) (2002 - 2024)
  • South San Francisco, CA (US) (2022 - 2024)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chronic Obstructive Pulmonary Disease
Neprilysin Inhibitors
Glycopeptide Antibiotics
Adrenergic Receptor Agonists
Muscarinic Receptor Antagonists
Protein Kinase Inhibitors
Cephalosporin Compounds
Aryl Aniline Compounds
Cross-Linked Antibiotics
Therapeutic Methods
Pharmaceutical Compounds
Drug Development
48 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor Edmund J Moran

Introduction:

In the realm of groundbreaking inventions, Edmund J Moran emerges as a prolific inventor based in San Francisco, CA (US). With an impressive portfolio of 45 patents to his name, Moran has significantly contributed to the field of pharmaceuticals and healthcare through his cutting-edge creations.

Latest Patents:

Among his latest patents, Moran shines through his remarkable work on Neprilysin inhibitors. These compounds exhibit neprilysin inhibition activity, paving the way for novel pharmaceutical compositions and treatment methods. Additionally, Moran's inventive methods for treating chronic obstructive pulmonary disease (COPD) showcase his dedication to enhancing patient care and treatment outcomes.

Career Highlights:

Throughout his career, Moran has made substantial strides in the industry, notably working with renowned companies such as Theravance, Inc. and Theravance Biopharma R&D IP, LLC. His innovative spirit and passion for advancing healthcare technologies have solidified his position as a trailblazer in the field of pharmaceutical innovations.

Collaborations:

Collaboration plays a pivotal role in Moran's professional journey, with esteemed coworkers like James Bradley Aggen and Seok-Ki Choi standing as testament to his ability to work synergistically towards common goals. Together, they have driven forward impactful research and development initiatives, contributing to the collective knowledge within the industry.

Conclusion:

In conclusion, Inventor Edmund J Moran's inventive prowess and unwavering commitment to advancing healthcare solutions have established him as a prominent figure in the world of pharmaceutical innovations. His remarkable patents and collaborative efforts underscore Moran's invaluable contributions to the field, shaping the future of healthcare for the better.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…